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Cocaine and many other psychostimulants strongly induce urokinase-type plasminogen activator (uPA)
expression in the mesolimbic dopaminergic pathway, which plays a major role in drug-mediated behav-
ioral plasticity [Bahi A, Boyer F, Gumy C, Kafri T, Dreyer JL. In vivo gene delivery of urokinase-type
plasminogen activator with regulatable lentivirus induces behavioral changes in chronic cocaine admin-
istration. Eur J Neurosci 2004;20:3473–88; Bahi A, Boyer F, Kafri T, Dreyer JL. Silencing urokinase in
the ventral tegmental area in vivo induces changes in cocaine-induced hyperlocomotion. J Neurochem
2006;98:1619–31; Bahi A, Dreyer JL. Overexpression of plasminogen activators in the nucleus accumbens
enhances cocaine-, amphetamine- and morphine-induced reward and behavioral sensitization. Genes
Brain Behav 2007]. In this study, the role of mesolimbic dopamine (DA) pathways in the development
of cocaine reward was examined by conditioned-place preference in rats with bilateral intra-accumbens
injections of uPA-expressing lentiviral vectors. We show that overexpression of uPA in the Nac signiﬁ-
cantly augments cocaine-induced place preference. Furthermore, while this did not affect the ability of
preference to be extinguished, reinstatement with a low dose of cocaine produced signiﬁcantly greater
preference to the cocaine-associated context. Once CPP had been established, and the preference extin-
guished, reinstatement induced by a priming dose of cocaine was facilitated by uPA. Inhibition of this
serine protease expression using doxycycline abolished the augmented acquisition produced by over-
expression of uPA but not the expression of the cocaine-induced CPP. When uPA is inhibited during the
acquisition phase, animals no longer demonstrate place preference for the environment previously paired
with cocaine. B428, a speciﬁc uPA inhibitor does not affect drug reinstatement after extinction if uPA
has been activated during acquisition, a clear indication that uPA is involved in the acquisition phase
of conditioned-place preference. Our results suggest that that increased uPA expression with repeated
drug exposure produces conditions for enhanced acquisition of cocaine-induced CPP, indicating that
cocaine-induced CPP and reinstatement may be dependent on active extracellular uPA.
1. Introduction
Plasminogen activators are important mediators of extracellu-
larmetabolism, involved in remodeling events duringdevelopment
and regeneration in the nervous system. The generation of plas-
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gen activator; siRNA, small interfering RNA; SNr, substantia nigra; tPA, tissue-type
plasminogen activator; uPA, urokinase-type plasminogen activator; uPAR, receptor
of uPA; VTA, ventral tegmental area.
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min from its inactive precursor plasminogen, is mediated by serine
enzymes known as tissue-type plasminogen activator (tPA) and
urokinase (uPA), and contributes to the turnover of the extracel-
lular matrix in the central nervous system [1]. Urokinase-type
plasminogen activator (uPA) exerts a variety of functions during
development, and is involved in learning and memory. Expres-
sion of uPA and its receptor, uPAR, may play an important role for
synaptogenesis, remodeling, and reactive processes other than for
cell migration in developing mouse brain [2]. Activity-dependent
synaptic plasticity and remodelingof themesolimbicdopaminergic
system play a crucial role in the development of drug dependence
[3–6]. It is well established that drugs of abuse, including the stim-
ulants cocaine and metamphetamine, as well as morphine, acutely
modulate the activity of mesolimbic dopaminergic neurons, pro-
jecting from the ventral tegmental area (VTA) of the midbrain to
the nucleus accumbens (NAc) [7–11]. Consistent with its hypoth-
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esized role in plasticity, uPA expression is strongly induced in the
mesolimbic dopaminergic pathway in response to psychostimu-
lant treatment [12]. In turn, uPA induces strong behavioral changes
associated with drug delivery. For example, metamphetamine-
induced dopamine release in the nucleus accumbens recruits the
plasminogen activator–plasmin system [13], inducing long-term
synaptic plasticity and remodeling, and increasing drug-induced
reward [14,15]. The plasmin system also participates in the reward-
ing effects of morphine by acutely regulating morphine-induced
dopamine release in the nucleus accumbens (NAc) [13,16]. A sin-
gle morphine treatment induced tPA expression in the NAc in a
naloxone-sensitive manner, with tPA expression diminishing after
repeatedmorphine administration. Conversely,morphine-induced
conditioned-place preference and hyperlocomotion were signiﬁ-
cantly reduced in tPA and plasminogen knockout mice, along with
an accompanying loss of dopaminergic reactivity in theNAc [16,17].
We have previously shown that genetic manipulation of uPA
expression in rats’ results in altered reactivity to cocaine adminis-
tration. Lentiviral-mediatedoverexpressionofuPA in theVTAof rats
increases doxycycline-dependent expression of its receptor, uPAR,
but not its inhibitor, plasminogen activator inhibitor-1 (PAI-1) [18].
TheexpressionofuPAR in theVTA is represseduponsilencingofuPA
with lentiviruses expressing siRNAs [18]. Associated with the over-
expressionofuPA in theVTA is a10-fold increase in locomotor activ-
ity following injection of cocaine [12]. However, animals expressing
the dominant-negative form of uPA failed to display such hyper-
locomotor activity [12]. These cocaine-induced behavioral changes,
associated with uPA expression, could be suppressed in the pres-
ence of doxycycline or of siRNA targeted against uPA [18,19].
Collectively, these and other data [13] strongly support amajor role
for urokinase in psychostimulant-mediated plasticity changes.
In the present study, we extended our previous observations
[12,18,19] by assessing the role of accumbal uPA overexpression
on the reinforcing properties of cocaine in the conditioned-place
preference (CPP) paradigm. Animals were injected into the nucleus
accumbens with lentiviruses expressing uPA, and various parame-
ters of place preference conditioning were assessed. We show that
uPA expression was important for the acquisition, but not expres-
sion of CPP. In addition, when uPAwas inhibited during acquisition,
animals displayed a memory deﬁcit and no longer associated the
environmentwithcocaine.After extinction,primingwith lowdoses
of cocaine reinstated place preference, but reinstatement of place
preferencewas strongly facilitateduponuPAexpression. Thesedata
conﬁrm that the plasmin system plays an important function in
the expression of drug dependence, mainly through activation of
extracellular proteases, e.g. uPA.
2. Materials and methods
2.1. Animals
Animals used in this experiment were male Wistar rats weighing 220–250g.
All animal experiments were carried out in accordance with the guidelines and
regulations for Animal Experimentation, BAG, Bern, Switzerland. The animals were
housed in trios in clear plastic cages with wire grid lids. Access to food and water
was unrestricted. The animals were kept in the animal facility maintained on a 12-h
light:12-h dark cycle (light off at 7 a.m.).
2.2. Lentivirus construction of LV-uPA and LV-GFP
Brieﬂy, the rat uPA cDNA was ampliﬁed by reverse transcription using super-
script II reverse transcriptase (Invitrogen, Switzerland) following themanufacturer’s
instructions. The cDNA was then PCR ampliﬁed, 6 His-tagged, digested with BamHI
and XhoI and cloned into similar sites in pTK431 [12,18,19]. A control vector con-
struct, pTK433 in which green ﬂuorescent protein (GFP) expression is regulated
by a tetracycline inducible promoter, was generated by cloning a BamHI/BglII DNA
fragment containing the GFP gene into a BamHI site in pTK431 [12,18,19–22]. All
plasmids were CsCl2 puriﬁed.
Vesicular stomatitis virus G pseudo-typed lentiviruses were produced by the
transient calcium phosphate co-transfection of HEK293T cells with pTK vectors
togetherwith pMDG-VSV-G and pNRF as previously described [12,18–23]. Lentivi-
ral vector quantiﬁcations were performed according to the p24 ELISA (KPL, USA) in
accordance with the manufacturer’s instructions.
2.3. Surgery
All surgical procedures were performed as previously described [12,18–22].
Brieﬂy, rats were anesthetized with a mix of ketamine/xylazine (100mg/kg/
10mg/kg, i.p.). Using a 5-l Hamilton syringe, 2l of concentrated lentiviral solu-
tions mix (ca. 200.000ng of p24 antigen/ml) per site were bilaterally injected into
the NAc or the dorsal striatum-, at the corresponding coordinates (NAc: anterior,
+1.4; lateral, ±1.6; ventral, −6.8; dorsal striatum: anterior, +0.7; lateral, ±3.2; ven-
tral, −4.5 [24]), with a rate of 1l/min, in a stereotaxic frame. The needle was
then left in place for an additional 5min and gently withdrawn. After surgery, ani-
mals were injected subcutaneously with 5ml of pre-warmed saline to avoid animal
dehydration. Animals were left 7 days to recover prior to experimentation.
2.4. Conditioned-place preference test
Conditioned-place preference was performed as previously described [25,26].
Brieﬂy, in the pre-conditioning period, rats were allowed to move freely between
two interconnected chambers (consisting of either wire grid ormesh ﬂoor) daily for
20min for 3 days (days 1–3). On day 3, the amount of time spent in each chamber
was monitored and used to assess unconditioned preferences. Prior to condition-
ing, the rats were divided into three groups (n=9/group). The ﬁrst group of animals
was fedwater supplementedwith 5% sucrose, the second group of animals received
water supplemented with 5% sucrose and 0.02% doxycycline during conditioning
“Acquisition” (days 3–9) and the third group of animals was fedwith the same solu-
tion during the post-conditioning “Expression” (day 10). We have shown previously
that when removed from the drinking water, doxycycline was signiﬁcantly elimi-
nated within 24h. Furthermore, when given to animals, doxycycline fully inhibits
ectopic gene expression in the same period of time [12,18,19]. During the condi-
tioning phase, rats were injected with cocaine (20mg/kg, i.p.; n=9/group) on days
4, 6, and 8 and immediately conﬁned in the ﬂoor-mesh box for 20min. It is well
established that CPP for cocaine develops in both rats and mice when injected with
cocaine 20mg/kg [25,27–34]. On days 5, 7, and 9, rats were injectedwith 0.9% saline
(1ml/kg) and placed in the wire grid chamber for 20min. During the conditioning
phase, a guillotine door blocked access between the two chambers. On day 10, the
post-conditioning “CPP” test was performedwithout drug treatment. Animals were
placed between the two chambers with the guillotine door removed and allowed
free access to the entire set-up. The time spent in each chamber was measured for
20min. Drug-induced place preference was expressed in seconds of preference for
pre- and post-conditioning, measured as time spent at the drug-conditioning site
during each conditioning periods.
2.4.1. Extinction
After conditioning and following the initial CPP test, rats (n=9/group) under-
went 20min tests daily for 10 days, but no injections were performed. Complete
extinction of CPP in cocaine-conditioned animals, deﬁned as the return to
exploratory times that did not differ signiﬁcantly from saline-injected control ani-
mals,was determined as the amount of time spent in each chamber being equivalent
to that of saline-injected control animals.
2.4.2. Reinstatement by cocaine priming after extinction
Animals were subjected to extinction as just described. Once complete extinc-
tion was established, animals (n=9/group) either received a priming i.p. injection
of 0.9% saline (1ml/kg) or cocaine (2mg/kg) immediately prior to a ﬁnal CPP test.
In experiments involving B428, a speciﬁc uPA inhibitor [35–37], animals
(n=9/group) were injected with B428 (30mg/kg, i.p.) in their home cage. 30min
later, ratswere injectedwith saline or r cocaine (2mg/kg, i.p. if uPAwas blocked dur-
ing priming experiments, or 15mg/kg in experimentswhere uPA had been inhibited
during conditioning), immediately prior to the ﬁnal CPP test (20min session).
2.4.3. Maintenance of CPP following withdrawal
After CPP testing, rats (n=9/group) underwent a 5-week period of withdrawal
during which animals were not handled, injected nor exposed to the conditioning
apparatus, but remained in their home cages. After this period, rats were placed
in the conditioning apparatus and allowed free access to both compartments for
20min.
2.5. Gel zymography
SDS-PAGE zymographywas performed as described previously [19]. Brieﬂy, rats
were sacriﬁced 24h after the last recording of the behavioral experiments. Brains
were quickly removed and NAc regions were rapidly dissected and used for protein
extraction. The tissuewas homogenized and protein concentrationsweremeasured
using the Bradford method. Equal amounts of protein extracts (10g) were mixed
with non-reducing SDS-PAGE sample buffer and run in a 10% SDS-PAGE gel con-
taining 0.1% casein (Sigma, Switzerland) and 12mU/ml plasminogen (Calbiochem,
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Fig. 1. LV-uPA enhances cocaine-induced place preference. Animals were injected with either LV-GFP or LV-uPA (n=9/group) and then manipulated as follows. Panels A–C:
rats were habituated to the CPP cages for 3 days and tested for baseline preference (pre-conditioning). Panels A′–C′: after the pre-conditioning phase, rats were trained for
conditioned-place preference (CPP) using 20mg/kg cocaine or 0.9% saline 1ml/kg for 6 days then tested for place preference (post-conditioning). The ﬁrst set of animals
received 5% sucrose drinking solution throughout the preconditioning, conditioning and test phases (Panels A and A′); the second group received 5% sucrose solution with
0.02% doxycycline during only the conditioning phase (CPP acquisition) (Panels B and B′); the third group received 5% sucrose solution and 0.02% doxycycline only during
the post-conditioning phase (i.e. CPP expression) (Panels C and C′). Values indicate means± S.E.M. *p<0.05 compared to LV-uPA injected animals; #p<0.05 compared to
saline-conditioned animals.
Switzerland). After electrophoresis the gel was washed and was then incubated
overnight in 100mM Tris–HCl, pH 8.1 and 15mM MgCl2 solution at 37 ◦C, stained
withCoomassie Brilliant Blue (Sigma, Switzerland) anddestainedwith solution con-
taining 35% methanol, 7% acetic acid. uPA activity was then observed in the gel as
light bands against a dark background.
2.6. Immunohistochemistry
Brain section staining was performed according to previously published pro-
cedures [12,18,19]. Brieﬂy, rats were sacriﬁced 24h after the last recording of the
behavioral experiments, brains were rapidly removed, frozen, and coronal sections
obtained on a cryostat. Slices were ﬁxed in 4% PFA for 15min, and washed three
times with 1× PBS. Sections were then rinsed and incubated overnight with mouse
anti-histidine antibody (MCA1396, Serotec, 1:12,000), washed and incubated with
the biotinylated secondary antibody (goat anti-mouse immunoglobulin G, Vector
Laboratories, Burlingame, CA, USA, 1:500). Sections were rinsed and incubated in
the avidin–biotin complex (Vector Laboratories). After three rinses in 1× PBS, all
sectionswere developed in 0.025% 3,3′-diaminobenzidine tetrahydrochloride (DAB)
plus 0.02% H2O2 for 10–15min. Sections were then dehydrated, mounted in perma-
nent medium (Eukitt) and examined with a Zeiss light microscope.
2.7. Statistical analysis
All behavioral data (differences in time spent between conditioned and
non-conditioned compartments) were analyzed by ANOVA using SPSS V11
software. Fundamental analysis of CPP used a three-way ANOVA ([LV-GFP/LV-
uPA× cocaine/saline×doxy/sucrose] or [LV×Drug×B428/Vehicle]). Additional
ANOVAs for the extinction phase incorporated repeated measures for the 10 days
of extinction. Main and interaction effects were deemed signiﬁcant at p<0.05,
and where appropriate were followed by pairwise comparisons using the Tukey
test.
3. Results
3.1. Lentivirus-mediated uPA expression in the NAc affects place
preference
To determine the effects of uPA expression on cocaine-mediated
place preference, animals were injected with either LV-uPA or
LV-GFP into the NAc. Gene expression by both vectors is regu-
lated by doxycycline, which was administered to separate groups
of animals to determine whether uPA expression was necessary
during acquisition or expression of CPP. Therefore, two separate
groups of animals were fed doxycycline either during CPP acqui-
sition (days 3–10), or during the expression phase of CPP (at day
10). A third group was given only sucrose-ﬂavored water with-
out doxycycline throughout all phases of the experiment. Data are
summarized in Fig. 1. Before conditioning (at day 3) all animals
were pretested for evidence of bias towards either compartment
in the conditioning apparatus (Fig. 1 A–C; F(5,60) = 1.1; p>1.00).
No evidence of bias was found, since during preconditioning, rats
spent the same amount of time in both chambers (F(11,120) = 0.26;
p>0.990) (see Fig. 1A–C). Animals were then conditioned for place
preference and tested on day 10. Saline-conditioned animals dis-
played no behavioral changes, whether they were fed water or
doxycycline, and their preference scores were unchanged after the
conditioning phase (F(5,60) = 1.105; p>0.379). However, between
subjects comparisons of saline versus cocaine-treated animals
showed that GFP-treated animals displayed cocaine-induced place
preference (F(5,60) = 48.81; p<0.005), irrespective of whether they
were fed doxycycline or not (see LV-GFP groups in Fig. 1B′ and
1C′: F(11,60) = 41.781; p<0.00001). Alternatively, uPA-treated ani-
mals displayed a much higher preference for the cocaine-paired
chamber (F(5,60) = 178.94; p<0.001) (Fig. 1A′) and spent approxi-
mately 90% of the time in this drug-associated chamber. However,
when uPA was not expressed during the conditioning phase (i.e. if
uPA-expression was inhibited by doxycycline during the acquisi-
tion period), cocaine-conditioned LV-uPA animals did not display
a greater preference than the cocaine-conditioned GFP-controls
(p>0.377 compared to GFP; p<0.001 compared to precondition-
ing; see Fig. 1B′). These uPA-treated animals, nevertheless, which
have been fed doxycycline during conditioning, displayed signiﬁ-
cant lower scores than the corresponding group that has not been
fed doxycycline (Fig. 1B′ and 1A′; F(11, 60) = 41.781; p<0.0005). How-
ever, if uPA expression was suppressed only during CPP expression
(i.e. if animals were fed doxycycline only at the end of the learn-
ingperiod (after day9)), cocaine-conditioned LV-uPAanimals again
showed approximately 90% preference for the drug-paired cham-
ber (Fig. 1C′; F(11,60) = 41.78; p<0.0001). These data suggest that the
enhancing effects of LV-uPAon cocaine-induced CPP are dependent
on the expression of uPA during the acquisition phase of condition-
ing, rather than during the expression phase of CPP, when animals
are tested for place preference.
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3.2. Effect of LV-uPA on extinction of CPP
Animals injected with either LV-GFP or LV-uPA, were trained
for conditioned-place preference, tested for CPP on day 10, and
then subjected to a series of extinction trials in which they were
re-exposed to the conditioning apparatus without any injections,
but were allowed free-access to both chambers. As shown in Fig. 2,
animals which had been conditioned with saline displayed no sig-
niﬁcant behavioral change during this extinction period, and kept
spending approximately 50% of the time in both compartments,
irrespective ofwhether theyhadbeen feddoxycycline or not during
either the conditioning (acquisition) or post-conditioning (expres-
sion) phase (Fig. 2A–C;within subject factor F(5,60) = 0.17; p>0.971).
In contrast, animals which had been conditioned with cocaine dis-
played progressive extinction over the 10-day period (within sub-
ject factor F(5,60) = 38.547; p<0.0001). The rate of extinction among
GFP-treated animals was not altered by doxycycline treatment.
Between subject analysis of day 5 versus day 6 revealed no signiﬁ-
cant difference (F(2,30) = 0.223; p>0.803 and F(2,30) = 1.234; p>0.319
for days 5 and 6, respectively), indicating that 5–6 days after the
CPP test, these GFP-treated animals were unable to distinguish
between the two compartments. uPA-treated animals displayed a
longer extinction latency, which lasted 7–8 days, but this was likely
due to the fact that place preference was initially much higher
(Fig. 2A′; between subject analysis for days 7 and 8, respectively
F(2,30) = 25.57; p<0.001 and F(2,30) = 23.64; p<0.001). This latter
effect inuPA-treatedanimalswasobservedboth ingroups feddoxy-
cycline during CPP expression and in animals not fed doxycycline
(Fig. 2A′ andC′;within subject analysis of doxycycline in expression
vs. no doxycycline p>0.06). In contrast, animals fed doxycycline
during the acquisition period already displayed lower place prefer-
ence at the initiation of extinction, similar to GFP-treated animals,
and showed an overlapping extinction rate to that observed in GFP-
treated animals (see Fig. 2B′; p>0.531). Alternatively, uPA-treated
animals feddoxycyclineonlyduring theexpressionphasedisplayed
extinction similar to animals under the normal (no doxy) regimen
(compare Fig. 2C′ vs. A′; p>0.183). Finally, at the end of the extinc-
tionprocess (day10) therewerenodifferences inpreference among
all the groups (between subject factor F(11,120) = 0.487; p>0.904).
This observation prompted us to proceed towards an assessment
of the effects of cocaine priming on reinstatement of CPP.
3.3. Reinstatement of cocaine-induced place preference following
extinction
After a 10-day extinction period, animals were given one single
injection of saline or cocaine and tested for CPP. Injection of saline
had no effect on reinstatement of place preference (see Fig. 3, upper
panels A–C; F(11,120) = 1.044; p>0.421), irrespective of whether they
had been fed doxycycline during either the acquisition phase or
the expression phase of place preference conditioning (between
subject factor compared to regimen: F(11,60) = 41.78; p>0.993). No
change was observed neither in cocaine (between subject factor
F(5,60) = 1.06; p>0.401) nor saline-conditioned animals (between
subject factor F(5,60) = 1.203; p>0.332). However, if animals were
given a single injection of a very low dose of cocaine (2mg/kg, i.p.),
drug-mediated place preference was immediately re-established
(F(11,120) = 121.48; p<0.0001) (Fig. 3 lower panels A; B′ and C′). This
was evident in the GFP-treated animals, who displayed a mod-
est preference for the drug-paired compartment and spent 60%
of the time in the drug compartment (F(5,60) = 56.303; p<0.005),
which was similar to the behavior observed before extinction
(F(11,120) = 1.198; p>0.308). In contrast, uPA-treated animals dis-
played a much stronger reinstatement of place preference, which
once more showed up to 90% exploration time in the drug-paired
compartment, as observed prior to extinction (Fig. 3A′ and C′;
F(5,60) = 175.52; p<0.0001). Nevertheless, the substantial magni-
tude of this reinstatement was not observed if animals had been
fed doxycycline during the initial acquisition phase of condition-
ing: under these conditions animals showed reinstatement of CPP
to the degree observed in GFP-treated animals given the priming
dose of cocaine (Fig. 3B′; between subject factor compared to LV-
GFPp>0.243;betweensubject factor compared to regimenwithout
doxycycline p<0.005; and between subject factor compared to
groups fed doxycycline in acquisition p<0.003, respectively). These
data once more indicate that uPA expression during acquisition
exerts effects that not only enhance the development of CPP (see
Fig. 1A′), but also endow animals with heightened responsiveness
to cocaine, such that prior evidence of learning returns in a more
robust form.
To further test this hypothesis, an uPA-speciﬁc inhibitor, B428
[35–37] was injected into the animals after establishment of
CPP. Animals treated with either LV-GFP or LV-uPA, were condi-
Fig. 2. Rate of extinction for cocaine-induced place preference in LV-uPA and LV-GFP-treated animals. Animals (n=9/group) were injected with LV-GFP or LV-uPA and
pretested, trained and tested for CPP as in Fig. 1 (Panels A–C and A′–C′). After CPP monitoring on day 10, rats were placed into the apparatus for 20min daily for 10 days. No
injections were given during this extinction period. Graphs A′–C′ represent post-training data during the 10 days of drug withdrawal period of cocaine-conditioned animals
and start at higher levels than graphs A–C that represent post-training data from saline-conditioned control animals. Values indicate means± S.E.M.
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Fig. 3. Greater reinstatement of cocaine-inducedplace preferencewith a priming dose of cocaine in conditioned LV-uPA animals subjected to extinction. Animals (n=9/group)
were injected with LV-GFP or LV-uPA and trained for CPP as in Fig. 1. After CPP monitoring on day 10, extinction was instituted as in Fig. 2. Following extinction, animals
were given one single injection of 0.9% saline (1ml/kg i.p.) (upper panels) or cocaine (2mg/kg) (lower panels) and tested for CPP for 20min. Values indicate means± S.E.M.
*p<0.05 compared to LV-uPA injected animals; #p<0.05 compared to saline-conditioned animals.
Fig. 4. Inhibition of uPA by B428 failed to alter conditioned-place preference reinstatement with low dose cocaine priming. Animals (n=9/group) were injected with LV-GFP
or LV-uPA and trained for CPP as in Fig. 1. After CPP monitoring on day 10, rats were placed daily into the apparatus for 20min for 10 days. During that period, injection with
B428 (30mg/kg, i.p.) was given 30min prior to injection with cocaine (2mg/kg, i.p.), and, immediately after cocaine injection, animals were exposed to the CPP chamber for
20min preference testing. Values indicate means± S.E.M. *p<0.05 compared to LV-uPA injected animals; #p<0.05 compared to saline-conditioned animals.
tioned for place preference and, after establishment of CPP, they
were submitted to a 10-day extinction period. Thereafter uPA
activity was inhibited by injecting B428 (30mg/kg i.p.) 30min
prior to CPP monitoring upon priming injection of a low dose
of cocaine (2mg/kg). Between subjects analysis revealed signif-
icant changes (F(11,120) = 102.73; p<0.0001). As shown in Fig. 4,
GFP-treated animals displayed slight but signiﬁcant place prefer-
ence after B428 treatment (between subject factor F(5,60) = 23.407;
p<0.005), irrespective of the doxycycline regimen given to these
animals during the establishment of CPP. In addition, uPA-treated
animals again immediately showed strong CPP reinstatement upon
lowdose cocaine priming, although uPA activitywas fully inhibited
under these conditions (between subject factor F(5,60) = 178.515;
p<0.0001). Again animals, which had been fed doxycycline only
during the acquisition phase, but not during expression, displayed
no difference compared to GFP-treatment animals under similar
conditions (p>1.00; Fig. 4B). If expressed during acquisition, uPA
promotes association of the drug with the environment, even if
Fig. 5. (A) Effects of the uPA inhibitor, B428, on CPP expression. Animals (n=9/group) were injected with LV-GFP or LV-uPA and trained for CPP as in Fig. 1 but during
conditioning, each virus groupwas injectedwith B428, to inhibit uPA expression, or the vehicle. Half an hour prior to conditioning, animals have been injected 30mg/kg B428
in their home cage, thereafter animals have been injected 15mg/kg cocaine (or saline) for conditioning. On test days no B428 injection is performed. *p<0.05 compared to
LV-injected animals after pre-conditioning; #p<0.05 compared to saline-conditioned animals; ∅p<0.05 compared to saline-conditioned GFP control animals. (B) Effects of
uPA overexpression in the dorsal striatum on acquisition of CPP. Two groups of animals (n=9/group) were injected with LV-GFP or LV-uPA in the dorsal striatum at following
coordinates: anterior, +0.7; lateral, ±3.2; ventral, −4.5 [24], and subsequently pretested, conditioned and tested for CPP as in Fig. 1. *p<0.05 compared to LV-injected animals
after pre-conditioning.
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it was no longer expressed at later stages (between subject fac-
tor p<0.001 vs. doxycycline fed animals). The inhibition of uPA
by B428 occurs for both endogenous (in LV-GFP-treated animals)
as well as ectopic uPA (in LV-uPA-treated animals). Therefore, as
an alternative to using doxycycline, and in order to determine
the role of endogenous uPA, the effect of B428 was assessed in
animals subjected to cocaine conditioning (Fig. 5A). The results
showed that B428 administration during acquisition suppresses
CPP to below that of preconditioning. Blockade of endogenous
uPA (GFP-treated animals) and exogenous uPA (in LV-uPA-treated
group) during acquisition altered expression of cocaine-induced
CPP (F(5,60) = 50.76; p<0.001). CPP is in fact augmented in LV-uPA-
injected animals when vehicle is given, but there is no CPP in both
GFP and uPA groups when B428 was injected. This indicates that
suppressing endogenous uPA activity during acquisition alters CPP
expression, which agrees with the ﬁnding that doxycycline inhibi-
tion of ectopic uPA during acquisition does alter CPP expression.
Furthermore, another group of animalswas treated in the dorsal
striatum, to better assess the speciﬁcity of the observed behavioral
effects with respect to the NAc (Fig. 5B). Clearly overexpression of
uPA in the dorsal striatum does not augment CPP upon cocaine
conditioning, compared to controls (F(5,60) = 1.22; p>0.521). This
indicates that the behavioral changes observed upon overexpres-
sion of uPA are probably very related to the NAc. Further studies
should be necessary to test this hypothesis.
In order to assess whether cocaine-induced place preference
could be retained after a prolonged period ofwithdrawal fromdrug
and drug-associated contexts, animals treated either LV-GFP or
LV-uPA were trained for conditioned-place preference, then main-
tained in their home cages for 5 weeks, without further training
and without drug injections. After this withdrawal period, ani-
mals were placed into the CPP set-up and place preference was
measured. As shown in Fig. 6, animals displayed enhanced CPP
scores (F(11,120) = 119.79; p<0.0001), while saline-conditioned ani-
mals displayed no preference (Fig. 6A–C; F(5,60) = 0.27; p>0.93). In
contrast, animals conditioned with cocaine showed enhanced CPP
scores (F(5,60) = 79.22; p<0.001), with LV-GFP-injected animals still
spending a statistically signiﬁcant amount of time in the drug com-
partment following reinstatement (Fig. 5; F(5,60) = 14.85;p<0.03). In
contrast, LV-uPA-treated animals spent more than 80% of the time
in the drug compartment, but only if uPA had been expressed dur-
ing the acquisition phase of the initial CPP training (F(5,60) = 159.48;
p<0.0001; Fig. 6A and C). If uPA expression was blocked during
acquisition, reinstatement of place preferencewas not signiﬁcantly
different from GFP-treated animals (p>0.986; Fig. 6B).
3.4. Immunohistochemistry, real-time RNA quantiﬁcation and
SDS-PAGE gel zymography of uPA
As shown in Fig. 7, the observed behavioral changes appear
to be related to the expression of uPA in the injected sites. In
the presence of doxycycline (either in acquisition or in expression
of CPP), uPA expression in the NAc is very low, correspond-
ing to cocaine-induced endogenous uPA expression (Fig. 7A).
Quantitative RT-PCR in these regions showed no signiﬁcant
changes in uPA mRNA expression in GFP-treated animals on
the doxycycline regimen, compared to a normal non-doxycycline
drinkingwater regimen. In LV-uPA-treated animals, uPA expression
was 2.9-fold higher under the normal drinking regimen, com-
pared to the doxycycline regimen (Fig. 7B). These changes are
reﬂected in protein changes observed in immunohistochemistry
(Fig. 7A).
It is also very likely that behavioral changes are associated with
the active enzyme, as shown by zymography (Fig. 7C). Zymograms
show two bands, a major bright one (at ca. 46kDa), corresponding
to the high-MW form of uPA, and minor bands (ca. 35kDa) from
a lower MW form of uPA. In the presence of doxycycline either in
acquisition or in expression of CPP, but also in presence of B428, all
groups displayed no active uPA. However, in the absence of doxy-
cycline, but also during cocaine priming, LV-GFP-treated animals
display no signiﬁcant enzyme activity, compared to LV-uPA-treated
animalswhere enzymeactivitywas very strong, in good correlation
with observed behavioral data. This is also found upon reinstate-
ment. These data strongly indicate that the active form of uPA is
involved in observed behavioral changes.
4. Discussion
The goal of the current work was to determine the impact of
uPA overexpression on CPP acquisition, extinction and/or rein-
statement. The results showed that uPA overexpression in the
NAc exerted a signiﬁcant impact on cocaine-induced CPP and aug-
mentedCPP, and led toamore robust re-enlistmentofCPP following
extinction. The effect was abolished if overexpression was turned
off with doxycycline. These effects have been generated by ectopic
increases of uPA, and would have been more conclusive about the
role of endogenous uPA if silencing of naturally produced uPA was
produced, which is a question for future investigations. Neverthe-
less results are clearly indicate that excess uPA localized to the
NAc promotes the development of cocaine-induced CPP. In con-
trast,whenendogenousuPAwas inhibitedduringacquisition, using
B428, animals displayed no CPP. Therefore, given that animals with
uPA lentivirus showed effects above and beyond the control virus
manipulation (GFP), it is clear that increased uPA expression with
repeated drug exposure produces conditions for enhanced acquisi-
tion of cocaine-inducedCPP.Moreover, this overexpression appears
to have a localized effect, since infusion of LV-uPA into the dorsal
striatumwas without signiﬁcant effect on the development of CPP.
Therefore, the present ﬁndings suggest that the impact of uPA in
theNAc is critical to uPA-induced augmentationof cocaine-induced
CPP.
Fig. 6. The effects of LV-uPA during acquisition of cocaine-induced place preference were retained after a 5-week withdrawal period. Animals (n=9/group) were injected
with LV-GFP or LV-uPA and trained for CPP as in Fig. 1. After CPP monitoring on day 10, rats were placed back in their home cages without testing or injection for 5 weeks.
After this withdrawal period, animals were submitted to a ﬁnal 20min test for CPP. Values indicate means± S.E.M. *p<0.05 compared to LV-uPA injected animals; #p<0.05
compared to saline-conditioned animals.
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Fig. 7. Immunohistochemistry, RT-PCR and zymography of uPA. (A) Immunohistochemistry for uPA at the site of injection of LV-GFP or LV-uPA. uPA protein expression was
visualized using an anti-His antibody. Animals were sacriﬁced 24h after the last CPP monitoring, brains were dissected out and processed for immunohistochemistry. Note
that uPA expression was not detected in LV-GFP injected animals or in the presence of doxycycline. (B) Coordinates of injection sites in the NAc (according to Ref. [24]). (C)
RT-PCR of uPA mRNA expression. The NAc of treated animals was dissected and processed for qRT-PCR (see Section 2). Note the high uPA overexpression in the absence of
doxycycline. (D) Zymography of uPA in NAc. The NAc was dissected at the end of behavioral analysis and processed for zymography (see Section 2). Zymograms display two
active forms of uPA, one major bright band (at approximately 46kDa) and a minor band (at ca. 35kDa) which correspond to the high and lowMW forms of uPA, respectively.
It is noteworthy that the LV-GFP groups conditioned with
cocaine showed only weak, but statistically signiﬁcant, devel-
opment of place preference. Therefore, it is possible that the
enhancing effects of uPA overexpression operate in the context
of suboptimal development of CPP. Needless to say, uPA overex-
pression shifted preference to 90% to that of the saline-associated
context. Therefore, there is little room for further augmentation
in the CPP paradigm, and consequently, other procedures, such
as self-administration may be better approaches for determining
whether suboptimal circumstances for drug-reinforced behavior
are enhanced by uPA. Furthermore, the fact that priming in uPA
animals led to stronger reinstatement of preference speaks either
to greater retention or greater rewarding effects of cocaine.
When uPA expression was inhibited by doxycycline during
acquisition of CPP, animals no longer demonstrated evidence of
having shown a greater or stronger association of the environment
with cocaine. Doxy has no effects on endogenous uPA expression,
since endogenousuPA is not doxycycline regulatable and inourpre-
vious work we have shown that within approximately 8h after the
introduction of doxycycline in the drinking ﬂuid, more than 90% of
the LV gene-suppressing doxycycline effects are reached,which has
also been conﬁrmed at the protein level Bahi et al. [12,20], and has
been repeatedly observed in other experiments in our laboratory
(unpublished data).
The rate of extinction was the same for all cocaine groups
no matter what uPA treatment they received. In all cases it took
approximately 6 days of extinction trials for a 50% reduction in CPP.
The greater number of sessions needed to abolish CPP in uPA over-
expressing rats was merely due to a higher starting point, but not
to a delay in extinction, implying that uPA overexpression probably
does not cause any alteration in extinction. However, after extinc-
tion, primingwith lowdoses of cocaine reinstatedplace preference.
Several studies have shown that reinstatement of cocaine-
seeking behavior occurs after drug priming [38,39], and the drug
itself triggers craving in human addicts [40,41]. Infusion of FN-439,
a broad-spectrumMMP inhibitor, prevented cocaine-mediated CPP
acquisition, blocked reinstatement of cocaine CPP and suppressed
subsequent cocaine-primedreinstatement [42]. This is in full agree-
ment with our ﬁnding using B428, a speciﬁc uPA inhibitor. Indeed,
one goal of the present work was to test whether an inhibitor of
uPA activity would also impair the acquisition of cocaine-induced
CPP behavior. B428, a potent and speciﬁc uPA inhibitor that blocks
both endogenous (in LV-GFP-treated animals) and ectopic uPA
(in LV-uPA-treated animals) prevented the development of aug-
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mented CPP in LV-uPA animals, but did not affect drug-induced
CPP reinstatement after extinction if LV-uPA had been active dur-
ing acquisition. Together these data clearly indicate that uPA plays
an important role in the acquisition but not expression of cocaine-
induced conditioned-place preference. By virtue of augmenting the
preference to a cocaine-associated context, the overexpression of
uPA prolongs, but does not maintain, the behavioral inclination for
exploring suchacontext in theabsenceof further cocaine treatment
(as demonstrated by normal extinction). That is, after 5 weeks of
withdrawal, CPPwas still evident to a greater degree in LV-uPA ani-
mals. Therefore, while the presence of uPA overexpressionmay not
produce resistance to extinction, animals appeared to show reten-
tion of the learning experience, as well as increased susceptibility
to the reinstating effects of cocaine, as already mentioned earlier.
It would be of interest to determine whether other potential inﬂu-
ences such as stress might have a similar effect in reinstating CPP
in LV-uPA animals previously conditioned with cocaine.
Urokinase plaminogen activator is an extracellular serine pro-
tease,which is expressed inmost brain regions in the CNS [1,43–45]
and exerts its main enzymatic actions by converting inactive pre-
cursor plasminogen to the active protease plasmin [46–48] and
by degrading certain components in extracellular matrix, such
as laminin [47,49–53]. The role of uPA for extracellular matrix
degradation and dendritic spine dynamics has been well estab-
lished [54,55]. In turn, plasmin plays an important role in neurite
extension and synaptic remodeling by altering the cell–matrix
interaction [56–58]. Its localized expressionduring neuronal devel-
opment suggests that plasmin-mediated proteolysis facilitates
neurite outgrowth and cell migration [59,60]. Plasmin regulates
a cascade of extracellular proteolytic activities involved in long-
term potentiation and depression [52,61–63] or in learning and
memory [63–66]. Endogenous uPAmay also regulate synaptic plas-
ticity through mechanisms independent of plasmin or laminin,
such as mediating an interaction betweenmicroglia and dopamin-
ergic neurons, in analogy to mechanisms proposed for tPA [67].
Activity-dependent synaptic plasticity and remodeling of the
mesolimbic dopaminergic system play a crucial role in the devel-
opment of drug dependence [3,10,68]. Except from our previous
studies, there is so far no mention of uPA on cocaine’s reward,
whereas in contrast tPA in amphetamine reward is gaining major
insight. We have shown that uPA is strongly overexpressed after
cocaine delivery under various paradigms (chronic, acute or binge)
and strongly affects behavior [12,18,19]. The present study ﬁrmly
consolidates these data and points to an important role of the
plasmin system in chronic cocaine. Other studies have shown
that the plasmin system releases dopamine in the NAc upon psy-
chostimulants, which activates long-term synaptic plasticity and
remodeling, and acutely participates in the rewarding effects of
drugs such as methamphetamine or morphine [13,14,16,17,69].
It has been shown that tPA regulates nicotine-induced reward
and dopamine release through protease activated receptor-1 [70].
Using themorphine self-administration procedure, the same group
described very recently that tPA deﬁcient mice display more mor-
phine intake inadose-dependentmanneras compared to theirwild
type littermates [71]. However, under a progressive ratio schedule
of morphine reinforcement, tPA null mice display a lower breaking
point than wild-type mice [71]. These results and those reported
here clearly support the hypothesis that plasminogen activators
(tPA and uPA) play a central role in synaptic plasticity and drug-
associated learning and memory phenomena.
There is some possibility that the dose of cocaine used in the
present study could be aversive to some extent, as one would
expect from sympathomimetic agents such as cocaine (a perplex-
ing issue thatBerridge, for example, has addressed).However,many
other authors have used this same dose of cocaine in similar con-
texts ([25,27–32]; Leri et al. [33,34]). In any case, while we did not
have a robust effect on CPP in the LV-GFP animals, it was never-
theless in the predicted direction, as opposed to ‘place aversion.’
Whatever the neurobiological reasons forwhyhighly arousing sub-
stances like cocaine result in dependent behavior, the dose that
we used was nevertheless effective as an unconditioned stimu-
lus. It is nevertheless possible that uPA rendered the “aversive”
effects of cocaine less intense or even more tolerable. This ques-
tionmight be better addressed through self-administration studies
where the operant behavior of the animal will provide an indica-
tion of whether uPA overexpression is altering the CNS response to
cocaine.
A question that needs to be further addressed in future studies
is whether there are neuroanatomical restrictions on the ability of
uPA overexpression to augment cocaine-induced place preference.
The current study was mainly restricted to overexpression in the
NAc, based on previous studies that showed very strong locomotor
changes when uPA was overexpressed in that brain region Bahi et
al. [12,20]. However, it is possible that increased expression of uPA
outside the NAccmight exert similar effects. This needs to be deter-
mined to conﬁrm whether unique interactions between uPA and
the neurons of the NAc are necessary and sufﬁcient to produce an
increase in place preference. Nevertheless, as already mentioned
earlier, a control experiment in the dorsal striatum showed no
signiﬁcant behavioral changes, implying that unique interactions
between uPA and the neurons of the NAc are necessary and suf-
ﬁcient to produce an increase in place preference. This however
requires further detailed studies.
In conclusion, the present study suggests that uPA in the
NAc facilitates and strengthens learning for a cocaine-associated
context, even after extinction, and while animals are under the
inﬂuence of a small priming dose of cocaine during reinstatement
testing. Although not directly tested, these ﬁndings suggest that
endogenousuPAmaymediate cocaine-associated contextual learn-
ing.
Acknowledgements
Supported, by a Swiss National Foundation grants 3100-059350
and 3100AO-100686 (JLD) and PHS grants MH60706 (AWK) and
NIEHS P30 ES05022 (AWK). The authors are also very grateful to C.
Deforel-Poncet for her skilful assistance. Authors are grateful toMr.
LittleﬁeldBA fromEisai Research Institute, Andover,Massachusetts,
USA, for providing B428.
References
[1] Masos T,Miskin R. Localization of urokinase-type plasminogen activatormRNA
in the adult mouse brain. Brain Res Mol Brain Res 1996;35:139–48.
[2] DelBigioMR,HosainS,AltumbabicM. Localizationofurokinase-typeplasmino-
gen activator, its receptor, and inhibitors in mouse forebrain during postnatal
development. Int J Dev Neurosci 1999;17:387–99.
[3] Nestler EJ.Molecular basis of long-termplasticity underlying addiction. Nat Rev
Neurosci 2001;2:119–28.
[4] Robinson TE, Kolb B. Persistent structural modiﬁcations in nucleus accum-
bens and prefrontal cortex neurons produced by previous experience with
amphetamine. J Neurosci 1997;17:8491–7.
[5] Robinson TE, Kolb B. Alterations in the morphology of dendrites and dendritic
spines in the nucleus accumbens and prefrontal cortex following repeated
treatment with amphetamine or cocaine. Eur J Neurosci 1999;11:1598–604.
[6] Robinson TE, Kolb B. Structural plasticity associated with exposure to drugs of
abuse. Neuropharmacology 2004;47(Suppl 1):33–46.
[7] Koob GF. Drugs of abuse: anatomy, pharmacology and function of reward path-
ways. Trends Pharmacol Sci 1992;13:177–84.
[8] Wise RA. Neurobiology of addiction. Curr Opin Neurobiol 1996;6:243–51.
[9] Wise RA. Addiction becomes a brain disease. Neuron 2000;26:27–33.
[10] Koob GF, Sanna PP, Bloom FE. Neuroscience of addiction. Neuron
1998;21:467–76.
[11] Di Chiara G, Bassareo V. Reward system and addiction: what dopamine does
and doesn’t do. Curr Opin Pharmacol 2007;7:69–76.
ht
tp
://
do
c.
re
ro
.c
h
8
[12] Bahi A, Boyer F, Gumy C, Kafri T, Dreyer JL. In vivo gene delivery of urokinase-
type plasminogen activator with regulatable lentivirus induces behavioral
changes in chronic cocaine administration. Eur J Neurosci 2004;20:3473–88.
[13] Yamada K, Nagai T, Nabeshima T. Drug dependence, synaptic plasticity, and
tissue plasminogen activator. J Pharmacol Sci 2005;97:157–61.
[14] Iwata N, Inada T, Harano M, Komiyama T, Yamada M, Sekine Y, et al. No asso-
ciation is found between the candidate genes of t-PA/plasminogen system
and Japanesemethamphetamine-related disorder: a collaborative study by the
Japanese Genetics Initiative for Drug Abuse. Ann N Y Acad Sci 2004;1025:34–8.
[15] Hyman SE. Addiction: a disease of learning and memory. Am J Psychiatry
2005;162:1414–22.
[16] Nagai T, Yamada K, Yoshimura M, Ishikawa K, Miyamoto Y, Hashimoto K, et al.
The tissueplasminogenactivator–plasmin systemparticipates in the rewarding
effect of morphine by regulating dopamine release. Proc Natl Acad Sci USA
2004;101:3650–5.
[17] Ripley TL, RochaBA,OglesbyMW,StephensDN. Increased sensitivity to cocaine,
and over-responding during cocaine self-administration in tPA knockout mice.
Brain Res 1999;826:117–27.
[18] Bahi A, Boyer F, Kafri T, Dreyer JL. Silencing urokinase in the ventral tegmental
area invivo induces changes in cocaine-inducedhyperlocomotion. JNeurochem
2006;98:1619–31.
[19] Bahi A, Dreyer JL. Overexpression of plasminogen activators in the nucleus
accumbens enhances cocaine-, amphetamine- and morphine-induced reward
and behavioral sensitization. Genes Brain Behav 2008;7(2):244–56.
[20] Bahi A, Boyer F, Kafri T, Dreyer JL. CD81-induced behavioral changes dur-
ing chronic cocaine administration: in vivo gene delivery with regulatable
lentivirus. Eur J Neurosci 2004;19:1621–33.
[21] Bahi A, Boyer F, Bussard G, Dreyer JL. Silencing dopamine D3-receptors in the
nucleus accumbens shell in vivo induces changes in cocaine-induced hyper-
locomotion. Eur J Neurosci 2005;21:3415–26.
[22] Bahi A, Boyer F, Kolira M, Dreyer JL. In vivo gene silencing of CD81 by lentiviral
expression of small interference RNAs suppresses cocaine-induced behavior. J
Neurochem 2005;92:1243–55.
[23] Naldini L, BlomerU,Gallay P,OryD,MulliganR,Gage FH, et al. In vivo genedeliv-
ery and stable transduction of nondividing cells by a lentiviral vector. Science
1996;272:263–7.
[24] Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. 4th edn. San
Diego, USA: Academic Press; 1998.
[25] Mueller D, Stewart J. Cocaine-induced conditioned place preference: rein-
statement by priming injections of cocaine after extinction. Behav Brain Res
2000;115:39–47.
[26] Itzhak Y, Martin JL. Cocaine-induced conditioned place preference in mice:
induction, extinction and reinstatement by related psychostimulants. Neu-
ropsychopharmacology 2002;26:130–4.
[27] Bohn LM, Gainetdinov RR, Sotnikova TD, Medvedev IO, Lefkowitz RJ, Dykstra
LA, et al. Enhanced rewarding properties of morphine, but not cocaine, in beta-
arrestin-2 knock-out mice. J Neurosci 2003;23:10265–73.
[28] Medvedev IO, Gainetdinov RR, Sotnikova TD, Bohn LM, Caron MG, Dykstra
LA. Characterization of conditioned place preference to cocaine in congenic
dopamine transporter knockout female mice. Psychopharmacology (Berl)
2005;180:408–13.
[29] Orsini C, Bonito-Oliva A, Conversi D, Cabib S. Susceptibility to conditioned place
preference induced by addictive drugs inmice of the C57BL/6 andDBA/2 inbred
strains. Psychopharmacology (Berl) 2005;181:327–36.
[30] Roma PG, Riley AL. Apparatus bias and the use of light and texture in place
conditioning. Pharmacol Biochem Behav 2005;82:163–9.
[31] Becker A, Schmitz M, Grecksch G. Kindling modiﬁes morphine, cocaine and
ethanol place preference. Exp Brain Res 2006;168:33–40.
[32] Font L, Aragon CM, Miquel M. Ethanol-induced conditioned place preference,
but not aversion, is blocked by treatment with d-penicillamine, an inactivation
agent for acetaldehyde. Psychopharmacology (Berl) 2006;184:56–64.
[33] Valjent E, Corbille AG, Bertran-Gonzalez J, Herve D, Girault JA. Inhibition of
ERK pathway or protein synthesis during reexposure to drugs of abuse erases
previously learned place preference. Proc Natl Acad Sci USA 2006;103:2932–7.
[34] Barot SK, Ferguson SM, Neumaier JF. 5-HT(1B) receptors in nucleus accumbens
efferents enhance both rewarding and aversive effects of cocaine. Eur J Neurosci
2007;25:3125–31.
[35] Towle MJ, Lee A, Maduakor EC, Schwartz CE, Bridges AJ, Littleﬁeld BA. Inhi-
bition of urokinase by 4-substituted benzo[b]thiophene-2-carboxamidines:
an important new class of selective synthetic urokinase inhibitor. Cancer Res
1993;53:2553–9.
[36] Evans DM, Sloan-Stakleff K. Suppression of the invasive capacity of human
breast cancer cells by inhibition of urokinase plasminogen activator via
amiloride and B428. Am Surg 2000;66:460–4.
[37] Todaro LB, Ladeda V, Bal de Kier Joffe E, Farias EF. Combined treatment with
verapamil, a calcium channel blocker, and B428, a synthetic uPA inhibitor,
impairs the metastatic ability of a murine mammary carcinoma. Oncol Rep
2003;10:725–32.
[38] deWit H, Stewart J. Reinstatement of cocaine-reinforced responding in the rat.
Psychopharmacology (Berl) 1981;75:134–43.
[39] Shaham Y, Shalev U, Lu L, DeWit H, Stewart J. The reinstatement model of drug
relapse: history, methodology and major ﬁndings. Psychopharmacology (Berl)
2003;168:3–20.
[40] Ludwig AM, Wikler A. Craving and relapse to drink. Q J Stud Alcohol
1974;35:108–30.
[41] Jaffe JH, Cascella NG, Kumor KM, Sherer MA. Cocaine-induced cocaine craving.
Psychopharmacology (Berl) 1989;97:59–64.
[42] Brown TE, Forquer MR, Cocking DL, Jansen HT, Harding JW, Sorg BA. Role of
matrix metalloproteinases in the acquisition and reconsolidation of cocaine-
induced conditioned place preference. Learn Mem 2007;14:214–23.
[43] Sappino AP,Madani R, Huarte J, Belin D, Kiss JZ,WohlwendA, et al. Extracellular
proteolysis in the adult murine brain. J Clin Invest 1993;92:679–85.
[44] Salles FJ, Strickland S. Localization and regulation of the tissue plasminogen
activator–plasmin system in the hippocampus. J Neurosci 2002;22:2125–34.
[45] Ma Z, Webb DJ, Jo M, Gonias SL. Endogenously produced urokinase-type
plasminogen activator is a major determinant of the basal level of activated
ERK/MAP kinase and prevents apoptosis in MDA-MB-231 breast cancer cells. J
Cell Sci 2001;114:3387–96.
[46] Vassalli JD, Sappino AP, Belin D. The plasminogen activator/plasmin system. J
Clin Invest 1991;88:1067–72.
[47] Werb Z. ECM and cell surface proteolysis: regulating cellular ecology. Cell
1997;91:439–42.
[48] Fiumelli H, Jabaudon D, Magistretti PJ, Martin JL. BDNF stimulates expression,
activity and release of tissue-type plasminogen activator in mouse cortical
neurons. Eur J Neurosci 1999;11:1639–46.
[49] Tsirka SE, Gualandris A, Amaral DG, Strickland S. Excitotoxin-induced neuronal
degeneration and seizure aremediated by tissue plasminogen activator. Nature
1995;377:340–4.
[50] Tsirka SE, Rogove AD, Bugge TH, Degen JL, Strickland S. An extracellular prote-
olytic cascade promotes neuronal degeneration in the mouse hippocampus. J
Neurosci 1997;17:543–52.
[51] Goldﬁnger LE, Jiang L, Hopkinson SB, Stack MS, Jones JC. Spatial regulation and
activity modulation of plasmin by high afﬁnity binding to the G domain of the
alpha 3 subunit of laminin-5. J Biol Chem 2000;275:34887–93.
[52] Nakagami Y, Abe K, Nishiyama N, Matsuki N. Laminin degradation by plasmin
regulates long-term potentiation. J Neurosci 2000;20:2003–10.
[53] Tsirka SE. Tissue plasminogen activator as amodulator of neuronal survival and
function. Biochem Soc Trans 2002;30:222–5.
[54] Fiorillo CD, Williams JT, Bonci A. D1-receptor regulation of synaptic potentials
in the ventral tegmental area after chronic drug treatment. Adv Pharmacol
1998;42:1002–5.
[55] Oray S, Majewska A, Sur M. Dendritic spine dynamics are regulated
by monocular deprivation and extracellular matrix degradation. Neuron
2004;44:1021–30.
[56] MoonenG,Grau-WagemansMP, Selak I. Plasminogenactivator–plasmin system
and neuronal migration. Nature 1982;298:753–5.
[57] McGuire PG, Seeds NW. Degradation of underlying extracellular matrix by sen-
sory neurons during neurite outgrowth. Neuron 1990;4:633–42.
[58] SheaTB, BeermannML. Regulationof neuronalmigration andneuritogenesis by
distinct surface proteases. Relative contribution of plasmin and a thrombin-like
protease. FEBS Lett 1992;307:190–4.
[59] Sumi Y, Dent MA, Owen DE, Seeley PJ, Morris RJ. The expression of tissue and
urokinase-type plasminogen activators in neural development suggests dif-
ferent modes of proteolytic involvement in neuronal growth. Development
1992;116:625–37.
[60] Ware JH, DiBenedetto AJ, Pittman RN. Localization of tissue plasminogen acti-
vator mRNA in the developing rat cerebellum and effects of inhibiting tissue
plasminogen activator on granule cell migration. J Neurobiol 1995;28:9–22.
[61] Frey U, Muller M, Kuhl D. A different form of long-lasting potentiation revealed
in tissue plasminogen activator mutant mice. J Neurosci 1996;16:2057–63.
[62] Baranes D, Lederfein D, Huang YY, Chen M, Bailey CH, Kandel ER. Tissue plas-
minogen activator contributes to the late phase of LTP and to synaptic growth
in the hippocampal mossy ﬁber pathway. Neuron 1998;21:813–25.
[63] Calabresi P, Napolitano M, Centonze D, Marﬁa GA, Gubellini P, Teule MA, et al.
Tissue plasminogen activator controlsmultiple forms of synaptic plasticity and
memory. Eur J Neurosci 2000;12:1002–12.
[64] Meiri N,Masos T, RosenblumK,Miskin R, Dudai Y. Overexpression of urokinase-
type plasminogen activator in transgenic mice is correlated with impaired
learning. Proc Natl Acad Sci USA 1994;91:3196–200.
[65] Madani R, Hulo S, Toni N, Madani H, Steimer T, Muller D, et al. Enhanced
hippocampal long-term potentiation and learning by increased neuronal
expression of tissue-type plasminogen activator in transgenic mice. EMBO J
1999;18:3007–12.
[66] Nicole O, Docagne F, Ali C, Margaill I, Carmeliet P, MacKenzie ET, et al. The
proteolytic activity of tissue–plasminogen activator enhances NMDA receptor-
mediated signaling. Nat Med 2001;7:59–64.
[67] NakajimaK,NagataK,KohsakaS. Plasminogenmediates an interactionbetween
microglia and dopaminergic neurons. Eur Neurol 1994;34(Suppl 3):10–6.
[68] Robinson TE, Berridge KC. Incentive-sensitization and addiction. Addiction
2001;96:103–14.
[69] Nagai T, Noda Y, Ishikawa K, Miyamoto Y, Yoshimura M, Ito M, et al. The role of
tissue plasminogen activator in methamphetamine-related reward and sensi-
tization. J Neurochem 2005;92:660–7.
[70] Nagai T, Ito M, Nakamichi N, Mizoguchi H, Kamei H, Fukakusa A, et al. The
rewards of nicotine: regulation by tissue plasminogen activator–plasmin sys-
tem through protease activated receptor-1. J Neurosci 2006;26:12374–83.
[71] Yan Y, Yamada K,Mizoguchi H, Noda Y, Nagai T, Nitta A, et al. Reinforcing effects
of morphine are reduced in tissue plasminogen activator-knockout mice. Neu-
roscience 2007;146:50–9.
ht
tp
://
do
c.
re
ro
.c
h
9
